Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.42 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HMGCR | P04035 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | CPT2 | P23786 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
| ▸ | ACLY | P53396 | 2/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Malonic Acid SCHEMBL5568061 | 0.82 | LDHA (0.56) | LDHASRRTSHRCYP2D6CYP2C19 | |
| SCHEMBL42256 | 0.81 | TSHR (0.36) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL4841368 | 0.81 | KDM4E (0.37) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL768330 | 0.79 | TSHR (0.35) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL5014188 | 0.79 | TSHR (0.35) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL6205755 | 0.79 | FFAR3 (0.43) | LDHASRRTSHRCYP2D6CYP2C19 | |
| SCHEMBL5974062 | 0.79 | TSHR (0.35) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL8981788 | 0.79 | TSHR (0.35) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL7629526 | 0.79 | TSHR (0.35) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL6861198 | 0.79 | TSHR (0.35) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4171806-B1 | TRIMETALLIC CATALYST MADE FROM NICKEL, MOLYBDENUM AND TUNGSTEN AND USE THEREOF IN A HYDROTREATMENT AND/OR HYDROCRACKING PROCESS | IFP ENERGIES NOW (FR) | 2024-05-15 | — | — | EP | claimed |
| EP-3218010-B1 | POLYMER COMPOSED OF REPEAT UNITS HAVING A BIOLOGICALLY ACTIVE MOLECULE ATTACHED THERETO VIA A PH-SENSITIVE BOND | SPIREA LTD (GB) | 2022-10-26 | — | — | EP | claimed |
| US-11020408-B2 | Polymer composed of repeat units having a biologically active molecule attached thereto via a pH-sensitive bond | SPIREA LIMITED (GB) | 2021-06-01 | — | — | US | claimed |
| EP-2496649-B2 | FILM-FORMING COMPOSITION CONTAINING AN AGENT CAPABLE OF TRAPPING FORMALDEHYDE | SAINT GOBAIN ADFORS (FR) | 2020-10-28 | — | — | EP | claimed |
| US-20200289531-A1 | POLYMER COMPOSED OF REPEAT UNITS HAVING A BIOLOGICALLY ACTIVE MOLECULE ATTACHED THERETO VIA A PH-SENSITIVE BOND | SPIREA LIMITED (GB) | 2020-09-17 | — | — | US | claimed |
| US-10709717-B2 | Polymer composed of repeat units having a biologically active molecule attached thereto via a pH-sensitive bond | SPIREA LIMITED (GB) | 2020-07-14 | — | — | US | claimed |
| EP-3491064-A1 | POLYMER DISPERSIONS WITH REDUCED EMISSION OF ACETALDEHYDE | Stahl International B.V. (NL) | 2019-06-05 | — | — | EP | claimed |
| EP-2268589-B1 | SIZING COMPOSITION FOR MINERAL FIBERS AND RESULTING PRODUCTS | SAINT GOBAIN ISOVER (FR) | 2018-06-13 | — | — | EP | claimed |
| WO-2018024559-A1 | POLYMER DISPERSIONS WITH REDUCED EMISSION OF ACETALDEHYDE | BASF SE (DE) | 2018-02-08 | — | — | WO | claimed |
| EP-2438025-B1 | MINERAL FIBER MAT CONTAINING A FORMALDEHYDE-TRAPPING AGENT, AND METHODS FOR MANUFACTURING SAME | SAINT-GOBAIN ADFORS (FR) | 2017-12-27 | — | — | EP | claimed |
| WO-2009136105-A2 | SIZING COMPOSITION FOR MINERAL FIBERS AND RESULTING PRODUCTS | SAINT-GOBAIN ISOVER (FR) | 2009-11-12 | — | — | WO | claimed |
| US-20090258042-A1 | Encapsulated Active Materials Containing Adjunct Crosslinkers | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2009-10-15 | — | — | US | claimed |
| WO-2009103615-A1 | IMPROVEMENTS RELATING TO BENEFIT PARTICLES | UNILEVER PLC (GB) | 2009-08-27 | — | — | WO | claimed |
| US-20070138671-A1 | Encapsulated active material with reduced formaldehyde potential | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2007-06-21 | — | — | US | claimed |
| US-20070138674-A1 | ENCAPSULATED ACTIVE MATERIAL WITH REDUCED FORMALDEHYDE POTENTIAL | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2007-06-21 | — | — | US | claimed |
| EP-1797947-A2 | Encapsulated active material with reduced formaldehyde potential | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 2007-06-20 | — | — | EP | claimed |
| EP-0739199-B1 | ESTRADIOL PENETRATION INTENSIFIER FOR TRANSDERMAL ADMINISTRATION | LOHMANN THERAPIE SYST LTS (DE) | 2002-04-03 | — | — | EP | claimed |
| US-6090404-A | SUSTAINED RELEASE PATCH | LTS LOHMANN THERAPIE-SYSTEME GMBH (DE) | 2000-07-18 | — | — | US | claimed |
| EP-0739199-A1 | ESTRADIOL PENETRATION INTENSIFIER FOR TRANSDERMAL ADMINISTRATION | LTS LOHMANN Therapie-Systeme GmbH (DE) | 1996-10-30 | — | — | EP | claimed |
| WO-1995019162-A1 | ESTRADIOL PENETRATION INTENSIFIER FOR TRANSDERMAL ADMINISTRATION | LTS LOHMANN THERAPIE-SYSTEME GMBH & CO. KG (DE) | 1995-07-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11020408-B2 | Polymer composed of repeat units having a biologically active molecule attached thereto via a pH-sensitive bond | IL1R1, SRRM2, H1-2 | LDHA 1008/4885SRR 111/4885TSHR 372/4885 |
| US-20200289531-A1 | POLYMER COMPOSED OF REPEAT UNITS HAVING A BIOLOGICALLY ACTIVE MOLECULE ATTACHED THERETO VIA A PH-SENSITIVE BOND | IL1R1, SRRM2, H1-2 | LDHA 1008/4885SRR 111/4885TSHR 372/4885 |
| US-10709717-B2 | Polymer composed of repeat units having a biologically active molecule attached thereto via a pH-sensitive bond | IL1R1, SRRM2, H1-2 | LDHA 1008/4885SRR 111/4885TSHR 372/4885 |
| US-20090258042-A1 | Encapsulated Active Materials Containing Adjunct Crosslinkers | CAPG, ANXA5, CD68 | LDHA 583/4885SRR 4219/4885TSHR 4750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.